HUE029401T2 - Process for the preparation of tiotropium bromide - Google Patents

Process for the preparation of tiotropium bromide Download PDF

Info

Publication number
HUE029401T2
HUE029401T2 HUE13704817A HUE13704817A HUE029401T2 HU E029401 T2 HUE029401 T2 HU E029401T2 HU E13704817 A HUE13704817 A HU E13704817A HU E13704817 A HUE13704817 A HU E13704817A HU E029401 T2 HUE029401 T2 HU E029401T2
Authority
HU
Hungary
Prior art keywords
hogy hogy
tiotropium bromide
reaction
demethyltiotropium
product
Prior art date
Application number
HUE13704817A
Other languages
English (en)
Hungarian (hu)
Inventor
Luis Sobral
Marcio TEMTEM
Rafael Antunes
Bruna Nunes
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of HUE029401T2 publication Critical patent/HUE029401T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUE13704817A 2012-02-10 2013-02-08 Process for the preparation of tiotropium bromide HUE029401T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT106142A PT106142B (pt) 2012-02-10 2012-02-10 Processo para a preparação de brometo de tiotrópio

Publications (1)

Publication Number Publication Date
HUE029401T2 true HUE029401T2 (en) 2017-02-28

Family

ID=47722310

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13704817A HUE029401T2 (en) 2012-02-10 2013-02-08 Process for the preparation of tiotropium bromide

Country Status (20)

Country Link
US (1) US9090607B2 (OSRAM)
EP (1) EP2814827B1 (OSRAM)
JP (1) JP6118826B2 (OSRAM)
KR (1) KR102011326B1 (OSRAM)
CN (1) CN104144928B (OSRAM)
AU (1) AU2013217467B2 (OSRAM)
BR (1) BR112014019736B1 (OSRAM)
CA (1) CA2863772C (OSRAM)
ES (1) ES2592555T3 (OSRAM)
HU (1) HUE029401T2 (OSRAM)
IL (1) IL234011A (OSRAM)
IN (1) IN2014DN07390A (OSRAM)
MX (1) MX352587B (OSRAM)
NZ (1) NZ628768A (OSRAM)
PH (1) PH12014501771A1 (OSRAM)
PL (1) PL2814827T3 (OSRAM)
PT (1) PT106142B (OSRAM)
RU (1) RU2634715C2 (OSRAM)
SG (1) SG11201404781QA (OSRAM)
WO (1) WO2013117886A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
CN104557905B (zh) * 2013-10-16 2018-02-23 天津金耀集团有限公司 一种噻托溴铵中间体的制备方法
KR20170019544A (ko) 2015-08-11 2017-02-22 삼성디스플레이 주식회사 곡면 액정표시장치 및 이의 제조방법
CN105807524B (zh) * 2016-05-30 2019-04-16 京东方科技集团股份有限公司 阵列基板、显示面板及显示装置
PT109740B (pt) * 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
WO2018154596A1 (en) * 2017-02-22 2018-08-30 Gbr Laboratories Pvt. Ltd. Process for synthesis of tiotropium bromide monohydrate
PT115583B (pt) 2019-06-17 2022-05-02 Hovione Farm S A Processo contínuo para a preparação de medicamentos anticolinérgicos
CN114890997A (zh) * 2022-04-20 2022-08-12 江苏联环药业股份有限公司 一种抗胆碱能药物噻格溴铵的制备工艺

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US648632A (en) 1898-05-16 1900-05-01 John A Parker Composite board.
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
GB0100753D0 (en) 2001-01-11 2001-02-21 Bate Matthew Data system
PL208137B1 (pl) * 2001-06-22 2011-03-31 Boehringer Ingelheim Pharma Bezwodny krystaliczny bromek tiotropium, sposób jego wytwarzania i zastosowanie krystalicznego monohydratu bromku tiotropium do wytwarzania krystalicznego bezwodnego bromku tiotropium
DE10200943A1 (de) 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
DE10212264A1 (de) * 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
JP5227790B2 (ja) 2005-05-02 2013-07-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
EP1879888A2 (en) 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Crystalline forms of tiotropium bromide
WO2007022531A2 (en) 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102005059602A1 (de) * 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
KR101395881B1 (ko) * 2005-12-19 2014-05-21 시코르, 인크. 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법
SI1869035T2 (sl) * 2005-12-19 2015-12-31 Sicor, Inc. Nove kristalne oblike tiotropij bromida in postopek njihove priprave
CN101360744A (zh) * 2005-12-19 2009-02-04 西科尔公司 纯和稳定的噻托溴铵
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
HRP20141004T1 (hr) * 2008-01-10 2015-02-13 Generics Novi postupak pripreme estera skopina
TW201020247A (en) * 2008-11-06 2010-06-01 Gruenenthal Gmbh Substituierte disulfonamide
CA2931876A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
CN101863885B (zh) * 2010-06-03 2012-05-30 南京金丹呈医药技术有限公司 一种噻托溴铵的制备方法

Also Published As

Publication number Publication date
IN2014DN07390A (OSRAM) 2015-04-24
PH12014501771B1 (en) 2014-11-10
CA2863772A1 (en) 2013-08-15
JP6118826B2 (ja) 2017-04-19
KR102011326B1 (ko) 2019-08-16
PT106142B (pt) 2014-07-18
JP2015506970A (ja) 2015-03-05
AU2013217467B2 (en) 2016-11-17
IL234011A (en) 2016-04-21
WO2013117886A1 (en) 2013-08-15
RU2014136706A (ru) 2016-04-10
US20150018556A1 (en) 2015-01-15
RU2634715C2 (ru) 2017-11-03
BR112014019736A2 (OSRAM) 2017-06-20
CN104144928B (zh) 2016-09-14
PH12014501771A1 (en) 2014-11-10
SG11201404781QA (en) 2014-09-26
CN104144928A (zh) 2014-11-12
MX2014009568A (es) 2014-11-21
NZ628768A (en) 2016-09-30
US9090607B2 (en) 2015-07-28
EP2814827A1 (en) 2014-12-24
EP2814827B1 (en) 2016-06-22
ES2592555T3 (es) 2016-11-30
PL2814827T3 (pl) 2016-12-30
PT106142A (pt) 2013-08-12
AU2013217467A1 (en) 2014-09-04
MX352587B (es) 2017-11-30
BR112014019736B1 (pt) 2020-10-06
CA2863772C (en) 2019-07-23
KR20140138687A (ko) 2014-12-04
IL234011A0 (en) 2014-09-30
BR112014019736A8 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
AU2013217467B2 (en) Process for preparing tiotropium bromide
AU2014339136C1 (en) Process for the preparation of a PDE4 inhibitor
JP2020518662A (ja) 化合物の結晶多形、その製造方法及び用途
AU2014339136A1 (en) Process for the preparation of a PDE4 inhibitor
US20090203724A1 (en) Solid and crystalline dutasteride and processes for preparation thereof
EP3360858B1 (en) Process for producing an aminopyrrolidine derivative
WO2014096214A1 (en) A process for preparation of rivaroxaban
WO2022192545A1 (en) Alpha v beta 6 and alpha v beta 1 integrin inhibitors and uses thereof
KR102937379B1 (ko) 프탈라지논 유도체 및 이의 중간체의 제조 방법
CN108586450B (zh) 一种胆碱m受体抗结剂的重结晶纯化方法
EP4635957A1 (en) Preparation method for stereoisomer and intermediate thereof
US20130053560A1 (en) Lamivudine oxalate and preparation method thereof
HK1256344B (en) Process for producing an aminopyrrolidine derivative
HUT55771A (en) Process for producing 6- and 7-deoxyphosphocolin and derivatives and pharmaceutical compositions containing them as active components
HK1223928B (en) Novel crystalline arylalkylamine compound and method for producing same
HK1181769A (en) Process for the preparation of glycopyrronium chloride